Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | EDNRB | P24530 | 1/20 | 0.38 |
| ▸ | EDNRA | P25101 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL547061 | 0.77 | CYP2A6 (0.50) | CYP17A1CYP2A6POLBRAB9AL3MBTL1 | |
| SCHEMBL547502 | 0.74 | CYP2A6 (0.47) | CYP17A1CYP2A6NPC1GAARAB9A | |
| SCHEMBL1622032 | 0.73 | PGR (0.41) | POLBNPC1GAARAB9APTGS1 | |
| SCHEMBL13766280 | 0.73 | EDNRB (0.38) | POLBNPC1GAARAB9AEDNRB | |
| SCHEMBL1942722 | 0.73 | RORB (0.45) | POLBNPC1GAARAB9AEDNRB | |
| SCHEMBL8649337 | 0.73 | CYP2A6 (0.60) | CYP17A1CYP2A6MAPK1ALDH1A1HPGD | |
| SCHEMBL1521833 | 0.69 | CYP2A6 (0.47) | CYP17A1CYP2A6 | |
| SCHEMBL27911621 | 0.69 | PRKCZ (0.40) | CYP17A1NPC1RAB9AFFAR4TDP1 | |
| Formic Acid SCHEMBL10703550 | 0.69 | CYP2A6 (0.44) | CYP17A1CYP2A6EDNRBEDNRAPTGS1 | |
| SCHEMBL28311793 | 0.69 | CYP2A6 (0.55) | CYP17A1CYP2A6MAPK1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090159876-A1 | ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC FIELD EFFECT TRANSISTOR | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-06-25 | — | — | US | disclosed |
| EP-1947706-A1 | ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC FIELD EFFECT TRANSISTOR | Mitsubishi Chemical Corporation (JP) | 2008-07-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090159876-A1 | ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC FIELD EFFECT TRANSISTOR | H1-4, OR10J3, EPCAM | CYP17A1 3652/4885CYP2A6 2391/4885POLB 3305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.